Camber Pharmaceuticals has been awarded the Premier Group’s 2025 Large Supplier of the Year, presented during the organization’s annual vendor meeting this November. The recognition reflects Camber’s decade-long partnership with the Premier Group and its ongoing commitment to stable, high-quality supply across its broad generic portfolio.
Camber currently offers more than 250 generic products and over 800 SKUs, including an expanding range of specialty and OTC medicines. This scale has established Camber as one of the nation’s most dependable and rapidly growing generic suppliers.
“This award is a direct result of strong collaboration and shared accountability,” said Stu Messinger, Director of National Accounts. “The Premier Group challenges us to think ahead, communicate early, and stay aligned so we can prevent disruptions before they reach their members or the patients they serve.”
Looking ahead, Camber plans to launch more than 60 new products in 2026 and submit over 50 new ANDAs, further strengthening supply continuity and affordability for its partners.
“Premier Group has been a valued partner for many years, and we are honored by this recognition,” said Kon Ostaficiuk, President of Camber Pharmaceuticals. “Our team remains focused on delivering high-quality, affordable medicines and supporting Premier members with the reliability they expect.”
For more information on upcoming launches, contact your Camber representative.
